https://www.selleckchem.com/products/ABT-888.html
To evaluate the rate of thrombosis, bleeding and mortality comparing anticoagulant doses in critically ill COVID-19 patients. Retrospective observational and analytical cohort study. COVID-19 patients admitted to the intensive care unit of a tertiary hospital between March and April 2020. 201 critically ill COVID-19 patients were included. Patients were categorized into three groups according to the highest anticoagulant dose received during hospitalization prophylactic, intermediate and therapeutic. The incidence of venous thromboembol
Mi piace
Commento
Condividi
